The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2023

Filed:

Dec. 09, 2021
Applicant:

Novartis Ag, Basel, CH;

Inventors:

Peng Fu, Suzhou, CN;

Yu Gai, Shanghai, CN;

Feng Gao, Shanghai, CN;

Weiyong Kong, Suzhou, CN;

Yadong Lu, Changshu, CN;

Zhongcheng Min, Shouzhou, CN;

Shaofeng Rong, Changshu, CN;

Chutian Shu, Shanghai, CN;

Can Wang, Suzhou, CN;

Ruidong Wang, Shanghai, CN;

Jibin Zhao, Suzhou, CN;

Xianglin Zhao, Shanghai, CN;

Yi Zhao, Xiangcheng, CN;

Jianguang Zhou, Suzhou, CN;

Benjamin Martin, Leymen, FR;

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/06 (2006.01); C07D 209/04 (2006.01); C07D 211/74 (2006.01);
U.S. Cl.
CPC ...
C07D 401/06 (2013.01); C07D 209/04 (2013.01); C07D 211/74 (2013.01);
Abstract

The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-(((2S,4S)-(4-ethoxy-1-(((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.


Find Patent Forward Citations

Loading…